Cyclacel Pharmaceuticals ... (CYCC)
undefined
undefined%
At close: undefined
0.43
-2.25%
Pre-market Jan 07, 2025, 04:30 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Net Income -22.55M -21.20M -18.89M -8.45M -7.83M -7.29M -7.47M -11.79M -14.34M -19.39M -10.15M -13.19M -15.24M -16.02M -19.57M -40.38M -24.05M -29.26M -29.42M -39.59M -18.46M
Depreciation & Amortization 31.00K 32.00K 43.00K 20.00K 20.00K 29.00K 32.00K 133.00K 210.00K 174.00K 70.00K 60.00K 241.00K 457.00K 668.00K 1.86M 299.00K 1.09M 1.55M 1.31M 929.00K
Stock-Based Compensation 1.47M 1.51M 1.16M 430.00K 466.00K 331.00K 266.00K 782.00K 745.00K 1.22M 357.00K 380.00K 882.00K 1.75M 810.00K 1.70M n/a n/a 2.20M 2.20M n/a
Other Working Capital 4.42M -3.74M -3.76M 31.00K 143.00K -327.00K 1.23M 439.00K 342.00K -1.03M -1.20M -239.00K 174.00K 516.00K 1.72M -969.00K 878.00K -5.42M -1.78M 921.00K -25.00K
Other Non-Cash Items 227.00K -967.00K -1.49M 347.00K -38.00K -165.00K 1.87M 782.00K 51.00K 322.00K -1.02M -787.00K -15.85M 338.00K 343.00K 1.31M -264.00K 13.41M 6.99M 14.79M 2.07M
Deferred Income Tax n/a 967.00K 1.49M -347.00K n/a n/a n/a -794.00K n/a n/a -5.50M -39.00K 15.24M -13.00K 326.00K 6.57M n/a n/a -1.81M -1.48M n/a
Change in Working Capital 4.71M -1.17M -853.00K 61.00K -2.06M 227.00K -308.00K 809.00K -1.12M -1.03M -1.95M 1.53M 751.00K -2.55M 2.23M -969.00K 878.00K -5.42M -1.03M 1.67M -25.00K
Operating Cash Flow -16.11M -20.83M -18.54M -7.93M -9.45M -6.70M -7.48M -10.08M -14.46M -18.70M -18.20M -12.04M -13.98M -16.04M -15.19M -29.91M -23.14M -20.17M -21.51M -21.09M -15.49M
Capital Expenditures -6.00K -7.00K -27.00K -96.00K -10.00K -39.00K -13.00K -3.00K -34.00K -309.00K -208.00K -12.00K -6.00K -8.00K -15.00K -366.00K -1.77M -667.00K -900.00K -4.45M -995.00K
Acquisitions n/a n/a n/a n/a 38.00K n/a n/a 12.00K n/a n/a n/a n/a n/a n/a n/a n/a -3.76M n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -3.06M -153.60M n/a -52.29M -79.98M -30.54M
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.48M 30.77M 136.44M 4.55M 78.39M 57.55M 32.76M
Other Investing Acitivies n/a n/a n/a n/a 38.00K n/a n/a 12.00K 96.00K 384.00K 5.90M 62.00K 5.00K 41.00K 91.00K n/a n/a 26.00K 1.50M n/a n/a
Investing Cash Flow -6.00K -7.00K -27.00K -96.00K 28.00K -39.00K -13.00K 9.00K 62.00K 75.00K 5.69M 50.00K -1K 33.00K 1.56M 27.34M -22.69M 3.91M 26.70M -26.87M 1.22M
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -11.00K -89.00K -269.00K 8.35M -965.00K 12.66M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid -201.00K -201.00K -201.00K -201.00K -201.00K -201.00K -201.00K -200.00K -201.00K -200.00K -305.00K n/a -364.00K n/a n/a -1.23M -1.22M -921.00K -1.22M n/a n/a
Other Financial Acitivies n/a n/a 4.57M 4.54M 4.05M n/a 200.00K n/a n/a -21.00K n/a 94.00K 3.00K n/a 314.00K n/a n/a 15.96M 1.22M 3.31M 33.00K
Financial Cash Flow 848.00K 3.00M 21.74M 29.50M 3.85M 429.00K 14.75M 6.59M 10.86M 12.20M 27.33M 3.98M 8.91M 33.40M 3.85M -1.24M 32.21M 57.40M -5.49M 59.62M 12.78M
Net Cash Flow -14.97M -18.21M 3.15M 21.52M -5.62M -6.41M 7.39M -3.92M -3.75M -6.96M 14.73M -8.04M -5.05M 18.00M -12.73M -6.76M -13.25M 41.12M -298.00K 11.66M -1.49M
Free Cash Flow -16.12M -20.83M -18.57M -8.03M -9.46M -6.74M -7.49M -10.08M -14.49M -19.01M -18.41M -12.05M -13.98M -16.05M -15.21M -30.27M -24.91M -20.84M -22.41M -25.53M -16.48M

Create Price Alert on CYCC

Your price alert will notify you when the stock price is above 0.45.

Add to Watchlist